Omega-3 fatty acids reduce obesity-induced tumor progression independent of GPR120 in a mouse model of postmenopausal breast cancer

Oncogene

Volumn 34, Issue 27, 2015, Pages 3504-3513

  Chung, H ^a   Lee, Y S ^a   Mayoral, R ^a,b   Oh, D Y ^a   Siu, J T ^c   Webster, N J ^a,d,e   Sears, D D ^a,d   Olefsky, J M ^a,d   Ellies, L G ^c,d  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOBESITY AGENT; G PROTEIN COUPLED RECEPTOR 120; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; OMEGA 3 FATTY ACID; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; G PROTEIN COUPLED RECEPTOR; O3FAR1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CANCER RISK; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LIPID DIET; MAMMARY GLAND FAT; MASTITIS; MOUSE; NONHUMAN; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TUMOR GROWTH; TUMOR VOLUME; UPREGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; COMPLICATION; DISEASE COURSE; EXPERIMENTAL MAMMARY NEOPLASM; GENETICS; METABOLISM; MOUSE MUTANT; OVARIECTOMY; PATHOLOGY; PHYSIOLOGY;

MUS;

ANIMALS; CELLS, CULTURED; DIET, HIGH-FAT; DISEASE PROGRESSION; FATTY ACIDS, OMEGA-3; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; OVARIECTOMY; POSTMENOPAUSE; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84939417589     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.283     Document Type: Article

References (37)

1. Golabek T, Bukowczan J, Chlosta P, Powroznik J, Dobruch J, Borowka A. Obesity and prostate cancer incidence and mortality: a systematic review of prospective cohort studies. Urol Int 2014; 92: 7-14.
2. Kolodecik T, Shugrue C, Ashat M, Thrower EC. Risk factors for pancreatic cancer: underlying mechanisms and potential targets. Front Physiol 2013; 4: 415.
3. Ligibel JA, Strickler HD. Obesity and its impact on breast cancer: tumor incidence, recurrence, survival, and possible interventions. Am Soc Clin Oncol Educ Book 2013; 52-59.
4. Patterson RE, Rock CL, Kerr J, Natarajan L, Marshall SJ, Pakiz B et al. Metabolism and breast cancer risk: frontiers in research and practice. J Acad Nutr Diet 2013; 113: 288-296.
5. van Kruijsdijk RC, van der Wall E, Visseren FL. Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev 2009; 18: 2569-2578.
6. Rose DP, Vona-Davis L. Influence of obesity on breast cancer receptor status and prognosis. Expert Rev Anticancer Ther 2009; 9: 1091-1101.
7. Fares H, Lavie CJ, DiNicolantonio JJ, O'Keefe JH, Milani RV. Omega-3 fatty acids: a growing ocean of choices. Curr Atheroscler Rep 2014; 16: 389.
8. Simopoulos AP. Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk. Exp Biol Med 2010; 235: 785-795.
9. Khaw KT. Dietary fats and breast cancer risk. BMJ 2013; 347: f4518.
10. Signori C, El-Bayoumy K, Russo J, Thompson HJ, Richie JP, Hartman TJ et al. Chemoprevention of breast cancer by fish oil in preclinical models: trials and tribulations. Cancer Res 2011; 71: 6091-6096.
11. Zheng JS, Hu XJ, Zhao YM, Yang J, Li D. Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies. BMJ 2013; 346: f3706.
12. Jing K, Wu T, Lim K. Omega-3 polyunsaturated fatty acids and cancer. Anticancer Agents Med Chem 2013; 13: 1162-1177.
13. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulinsensitizing effects. Cell 2010; 142: 687-698.
14. Li P, Lu M, Nguyen MT, Bae EJ, Chapman J, Feng D et al. Functional heterogeneity of CD11c-positive adipose tissue macrophages in diet-induced obese mice. J Biol Chem 2010; 285: 15333-15345.
15. Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Ann Rev Physiol 2010; 72: 219-246.
16. Cui LF, Guo XJ, Wei J, Liu FF, Fan Y, Lang RG et al. Overexpression of TNF-alpha and TNFRII in invasive micropapillary carcinoma of the breast: clinicopathological correlations. Histopathology 2008; 53: 381-388.
17. Sheen-Chen SM, Chen WJ, Eng HL, Chou FF. Serum concentration of tumor necrosis factor in patients with breast cancer. Breast Cancer Res Treat 1997; 43: 211-215.
18. Handgraaf S, Riant E, Fabre A, Waget A, Burcelin R, Liere P et al. Prevention of obesity and insulin resistance by estrogens requires ERalpha activation function-2 (ERalphaAF-2), whereas ERalphaAF-1 is dispensable. Diabetes 2013; 62: 4098-4108.
19. Subbaramaiah K, Howe LR, Bhardwaj P, Du B, Gravaghi C, Yantiss RK et al. Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prev Res 2011; 4: 329-346.
20. Healy LA, Ryan AM, Carroll P, Ennis D, Crowley V, Boyle T et al. Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer. Clin Oncol 2010; 22: 281-288.
21. Maccio A, Madeddu C. Obesity, inflammation, and postmenopausal breast cancer: therapeutic implications. Sci World J 2011; 11: 2020-2036.
22. Simpson ER, Brown KA. Minireview: obesity and breast cancer: a tale of inflammation and dysregulated metabolism. Mol Endocrinol 2013; 27: 715-725.
23. Wong SW, Kwon MJ, Choi AM, Kim HP, Nakahira K, Hwang DH. Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen speciesdependent manner. J Biol Chem 2009; 284: 27384-27392.
24. Manni A, Richie JP Jr, Xu H, Washington S, Aliaga C, Bruggeman R et al. Influence of omega-3 fatty acids on Tamoxifen-induced suppression of rat mammary carcinogenesis. Int J Cancer 2014; 134: 1549-1557.
25. Parada B, Reis F, Cerejo R, Garrido P, Sereno J, Xavier-Cunha M et al. Omega-3 fatty acids inhibit tumor growth in a rat model of bladder cancer. Biomed Res Int 2013; 2013: 368178.
26. Seki E, Brenner DA, Karin M. A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Gastroenterology 2012; 143: 307-320.
27. Ramos-Nino ME. The role of chronic inflammation in obesity-associated cancers. ISRN Oncol 2013; 2013: 697521.
28. Sundaram S, Johnson AR, Makowski L. Obesity, metabolism and the microenvironment: links to cancer. J Carcinog 2013; 12: 19.
29. Calviello G, Su HM, Weylandt KH, Fasano E, Serini S, Cittadini A. Experimental evidence of omega-3 polyunsaturated fatty acid modulation of inflammatory cytokines and bioactive lipid mediators: their potential role in inflammatory, neurodegenerative, and neoplastic diseases. Biomed Res Int 2013; 2013: 743171.
30. de Lorgeril M, Salen P. New insights into the health effects of dietary saturated and omega-6 and omega-3 polyunsaturated fatty acids. BMC Med 2012; 10: 50.
31. Iyengar NM, Hudis CA, Gucalp A. Omega-3 fatty acids for the prevention of breast cancer: an update and state of the science. Curr Breast Cancer Rep 2013; 5: 247-254.
32. Sczaniecka AK, Brasky TM, Lampe JW, Patterson RE, White E. Dietary intake of specific fatty acids and breast cancer risk among postmenopausal women in the VITAL cohort. Nutr Cancer 2012; 64: 1131-1142.
33. Kang KS, Wang P, Yamabe N, Fukui M, Jay T, Zhu BT. Docosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase 8 activation. PLoS ONE 2010; 5: e10296.
34. MacLennan MB, Clarke SE, Perez K, Wood GA, Muller WJ, Kang JX et al. Mammary tumor development is directly inhibited by lifelong n-3 polyunsaturated fatty acids. J Nutr Biochem 2013; 24: 388-395.
35. Xue M, Wang Q, Zhao J, Dong L, Ge Y, Hou L et al. Docosahexaenoic acid inhibited the Wnt/beta-catenin pathway and suppressed breast cancer cells in vitro and in vivo. J Nutr Biochem 2014; 25: 104-110.
36. Wu Q, Wang H, Zhao X, Shi Y, Jin M, Wan B et al. Identification of G-proteincoupled receptor 120 as a tumor-promoting receptor that induces angiogenesis and migration in human colorectal carcinoma. Oncogene 2013; 32: 5541-5550.
37. Biswas T, Gu X, Yang J, Ellies LG, Sun LZ. Attenuation of TGF-beta signaling supports tumor progression of a mesenchymal-like mammary tumor cell line in a syngeneic murine model. Cancer Lett 2014; 346: 129-138.